Skip to main navigation Skip to search Skip to main content

Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls

  • Matthew Randesi
  • , Wim van den Brink
  • , Orna Levran
  • , Vadim Yuferov
  • , Peter Blanken
  • , Jan M. van Ree
  • , Jurg Ott
  • , Mary Jeanne Kreek

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

To determine whether specific dopaminergic system gene variants are associated with opioid dependence. Subjects included 153 healthy controls, 163 opioid exposed, but not dependent and 281 opioid dependent. Genotypes of 90 variants in 13 genes were examined. The most significant results were obtained for DA β-hydroxylase variants, rs2073837 and rs1611131, which were associated with protection from addiction (q = 0.0172, 0.0415, respectively) and the functional TH variant, rs2070762, was associated with more risk (q = 0.0387). The three variants also showed a combined effect that remained significant after correction for multiple testing (pfinal = 0.0039). These data offer support that dopaminergic gene variants have a role in opioid dependence and warrant further study
Original languageEnglish
Pages (from-to)95-104
JournalPharmacogenomics
Volume19
Issue number2
Early online date2017
DOIs
Publication statusPublished - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls'. Together they form a unique fingerprint.

Cite this